|
Iloperidone Sublicense to Novartis Pharma AG (Details Textual) (Novartis [Member])
|
12 Months Ended |
|---|---|
|
Dec. 31, 2013
|
|
|
Minimum [Member]
|
|
| Operating Leased Assets [Line Items] | |
| Percentage of next slab of annual sales for calculating net royalty | 8.00% |
|
Maximum [Member]
|
|
| Operating Leased Assets [Line Items] | |
| Percentage of next slab of annual sales for calculating net royalty | 10.00% |
| X | ||||||||||
|
- Definition
Percentage of next slab of annual sales for calculating net royalty. No definition available.
|
| X | ||||||||||
|
- Details
|